1. Home
  2. TENX vs LITB Comparison

TENX vs LITB Comparison

Compare TENX & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • LITB
  • Stock Information
  • Founded
  • TENX 1967
  • LITB 2007
  • Country
  • TENX United States
  • LITB Singapore
  • Employees
  • TENX N/A
  • LITB N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • TENX Health Care
  • LITB Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • LITB Nasdaq
  • Market Cap
  • TENX 25.0M
  • LITB 21.1M
  • IPO Year
  • TENX N/A
  • LITB N/A
  • Fundamental
  • Price
  • TENX $5.99
  • LITB $1.20
  • Analyst Decision
  • TENX Strong Buy
  • LITB
  • Analyst Count
  • TENX 3
  • LITB 0
  • Target Price
  • TENX $15.00
  • LITB N/A
  • AVG Volume (30 Days)
  • TENX 15.7K
  • LITB 12.7K
  • Earning Date
  • TENX 08-13-2025
  • LITB 09-10-2025
  • Dividend Yield
  • TENX N/A
  • LITB N/A
  • EPS Growth
  • TENX N/A
  • LITB N/A
  • EPS
  • TENX N/A
  • LITB 0.08
  • Revenue
  • TENX N/A
  • LITB $231,136,000.00
  • Revenue This Year
  • TENX N/A
  • LITB N/A
  • Revenue Next Year
  • TENX N/A
  • LITB N/A
  • P/E Ratio
  • TENX N/A
  • LITB $15.16
  • Revenue Growth
  • TENX N/A
  • LITB N/A
  • 52 Week Low
  • TENX $3.25
  • LITB $0.91
  • 52 Week High
  • TENX $7.89
  • LITB $4.80
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.19
  • LITB 44.21
  • Support Level
  • TENX $5.88
  • LITB $1.15
  • Resistance Level
  • TENX $6.02
  • LITB $1.33
  • Average True Range (ATR)
  • TENX 0.13
  • LITB 0.10
  • MACD
  • TENX -0.01
  • LITB -0.01
  • Stochastic Oscillator
  • TENX 70.37
  • LITB 19.07

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: